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The World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) posttraumatic stress disorder (PTSD) module
is widely used in epidemiological studies of PTSD, yet relatively few data attest to the instrument’s diagnostic utility. The current study
evaluated the diagnostic utility of the CIDI 3.0 PTSD module with U. S. women Vietnam-era veterans. The CIDI and the Clinician-
Administered PTSD Scale (CAPS) were independently administered to a stratified sample of 160 women, oversampled for current PTSD.
Both lifetime PTSD and recent (past year) PTSD were assessed within a 3-week interval. Forty-five percent of the sample met criteria for
a CAPS diagnosis of lifetime PTSD, and 21.9% of the sample met criteria for a CAPS diagnosis of past-year PTSD. Using CAPS as the
diagnostic criterion, the CIDI correctly classified 78.8% of cases for lifetime PTSD (κ = .56) and 82.0% of past year PTSD cases (κ =
.51). Estimates of diagnostic performance for the CIDI were sensitivity of .61 and specificity of .91 for lifetime PTSD and sensitivity of
.71 and specificity of .85 for past-year PTSD. Results suggest that the CIDI has good utility for identifying PTSD, though it is a somewhat
conservative indicator of lifetime PTSD as compared to the CAPS.
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The World Health Organization (WHO) Composite Interna-
tional Diagnostic Interview (CIDI) posttraumatic stress disorder
(PTSD) module is one of the most widely used epidemiological
measures of PTSD worldwide. The CIDI version 3.0 (Kessler &
Ustun, 2004) was used to identify PTSD and other mental health
conditions in the WHO World Mental Health Survey Initiative
(Kessler et al., 2007), including the U.S. National Comorbid-
ity Survey and other Collaborative Psychiatric Epidemiological
Surveys (Kessler, Chiu, Demler, Merikangas, & Walters, 2005).
The CIDI is used internationally for epidemiological studies
because it addresses a wide range of mental health conditions,
can be administered by trained lay interviewers, and offers a
sophisticated computer-assisted telephone interview (or CATI)
version. Studies calibrating the CIDI against clinical diagnoses,
however, have found only moderate support for its accuracy in
identifying PTSD (Haro, 2006; Alegria, 2004; Breslau, Kessler
& Peterson, 1998). In addition, no studies to date have assessed
the diagnostic performance of the CIDI PTSD module in pop-
ulations of women or of veterans.
Structured clinical interviews are considered to be a method-
ologically rigorous diagnostic criterion in evaluation of mea-
sures of mental health conditions. Both the Structured Clin-
ical Interview for DSM-IV (SCID; First, Spitzer, Gibbon, &
Williams, 2002) and the Clinician-Administered PTSD Scale
(CAPS; Blake et al., 1995) are structured clinical interviews
used widely to generate gold standard diagnoses for PTSD.
The concordance between this diagnostic criterion or gold stan-
dard diagnosis, and the test diagnosis (i.e., the measure being
evaluated) yield estimates of diagnostic accuracy.
Studies of diagnostic accuracy can utilize a variety of statisti-
cal indicators. Diagnoses for both the test and criterion measure
should be reported to indicate prevalence and to demonstrate
that there are sufficient numbers of positive and negative tests to
calculate estimates of diagnostic concordance with reasonable
precision (Kraemer, 1992). Most studies evaluate concordance
using receiver operating curve (ROC) characteristics (Kraemer,
1992; McNeil & Hanley, 1984) such as sensitivity, or “hit rate,”
the probability that a positive test detects a true diagnosis; and
specificity, the probability of a true negative diagnosis. A test
with good sensitivity has few false negative diagnoses, where as
a test with good specificity has few false positive diagnoses. The
diagnostic likelihood ratio (LR) is a function of sensitivity and
specificity, but is useful due the ease of interpretation (Sackett,
2009). The LR expresses the certainty of the test diagnosis rela-
tive to the diagnostic criterion. An LR ranges from 0 to infinite
where values> 1 yield increased certainty of the diagnosis, and
values < 1 lend certainty that the diagnosis can be ruled out.
The LR+ expresses the likelihood of a positive diagnosis given
a positive test, whereas the LR− indicates the likelihood of a
negative diagnosis for a negative test result. An LR+ > 5 or
LR−< 0.2 suggests strong probability of the condition, where
LR+ > 10 or LR− < 0.1 are considered definitive. LRs can
then be combined with prevalence to determine the probability
of a diagnosis for a positive test (positive predictive value) and
the probability the condition is absent with a negative test (neg-
ative predictive value). Indicators of overall agreement between
a measure and the diagnostic criterion include the area under
the ROC curve, an index of the test’s ability to discriminate
between individuals with and without the disorder, and κ coef-
ficients, the chance corrected probability that the test and the
criterion agree. Kappa coefficients have been conceptualized as
good indicators of the quality of a test because it is a calibrated
indicator of agreement (Kraemer, 1992).
Two studies have examined the diagnostic performance of the
CIDI relative to the SCID. In the clinical calibration of a variety
of CIDI modules for the World Mental Health Surveys, clin-
ical reappraisal interviews using the SCID were administered
to a probability subsample of 325 survey respondents who had
participated in the National Comorbidity Survey Reappraisal
(NCS-R) within the past 2 months (Haro et al., 2006). The
study used a partially unblinded design, whereby respondents
were cued to their prior responses to CIDI stem questions. The
number of CIDI lifetime PTSD diagnoses was not reported.
These data suggested moderate concordance between the CIDI
and SCID for lifetime PTSD with a sensitivity of .38 (SE =
.12), and a specificity of .99 (SE = .50), κ of .49 (SE = .10)
and the area under the ROC curve of .69. The positive predic-
tive value was 86.1% (SE = 7.7) and the negative predictive
value was 91.3% (SE = 3.0). The concordance between past-
year CIDI and SCID diagnoses was examined in a sample of
195 U.S. Latinos from the National Latino and Asian American
Study (Alegria et al., 2004) using blinded, independent admin-
istration of the SCID. Only five cases of PTSD were diagnosed
using the SCID, which meant that there were too few criterion
diagnoses among the participants to obtain stable estimates of
diagnostic accuracy. Of the five diagnosed with PTSD by the
SCID, one met criteria for subthreshold PTSD on the CIDI, but
none received a PTSD diagnosis with the CIDI. Seven other
participants received PTSD diagnoses on the CIDI.
The CAPS is commonly viewed as the standard clinical in-
terview for DSM-IV (4th ed., DSM-IV, American Psychiatric
Association, 2000) PTSD (Weiss, 2004). The CAPS is ideal as a
diagnostic criterion for PTSD for several reasons: It provides a
detailed assessment of both trauma exposure and the frequency
and intensity of PTSD symptoms, and it can be scored to obtain
a dichotomous indicator of a PTSD diagnosis as well as a con-
tinuous measure of symptom severity. To date, we are aware of
only one study that compared the CIDI to the CAPS, examin-
ing concordance for lifetime PTSD diagnoses. This study was a
clinical reappraisal of participants from the Detroit Area Study
of Trauma (Breslau, Kessler, & Peterson, 1998), which used a
modified version of the CIDI 2.1. In this study, 53 individu-
als who completed the CIDI 2.1 as part of the original survey
were stratified by their survey PTSD diagnosis (32 with life-
time PTSD on the CIDI, 23 without lifetime PTSD on the CIDI,
matched on type of trauma exposure) and completed blinded
CIDI and CAPS interviews approximately 12–18 months fol-
lowing survey participation. Survey CIDI diagnoses were com-
pared to CAPS diagnoses, yielding a sensitivity of .95 (95%
confidence interval [CI] = [.75, 1.0]), specificity of .71, 95%
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CI = [.52, .85], and 81% agreement. Weighted estimates of
the positive predictive value and the negative predictive value
were 75 (95% CI = [30, 97]) and 97 (95% CI = [86, 100]),
respectively. Although these data lend greater confidence to the
diagnostic accuracy of the CIDI’s PTSD module as compared
to other studies, additional data on the CIDI 3.0 are needed.
To date, there are limited data that can attest to the diag-
nostic utility of the CIDI’s PTSD module. The prevalence of
recent PTSD in the general population is sufficiently low to
present a challenge to obtaining sample sizes large enough to
estimate diagnostic concordance with a clinical gold standard,
and accordingly the diagnostic utility of the CIDI for recent
PTSD is unknown (Haro, 2006). The low sensitivity obtained
from the NCS-R calibration study despite a partially unblinded
design suggests a need for further evaluation. Furthermore, the
performance of a diagnostic test may vary across populations,
so studies that examine the utility of the CIDI with popula-
tions at high risk for PTSD, such as women or veterans may
be especially informative. The goal of the current study was to
evaluate the diagnostic concordance of the CIDI PTSD module
with clinical assessment using the CAPS (Blake et al., 1995)
in a sample of women Vietnam-era veterans. We examined the
diagnostic certainty of the CIDI PTSD module relative to the
CAPS, which has been extensively used to establish clinical di-
agnoses of PTSD among both veteran and civilian populations
(Weathers, Keane, & Davidson, 2001). Diagnostic concordance
between the CIDI and CAPS was evaluated for both lifetime
and past-year PTSD.
Method
Participants
The study population was drawn from participants who com-
pleted a larger epidemiological study of the health status of
women veterans who served during the Vietnam-era (Thomas,
Kang, & Dalager, 1991) and agreed to participate in the
HealthViEWS study. Eligibility criteria for HealthViEWS in-
cluded the following: women who served as active duty military
personnel in one of the four U.S. Armed Services (Army, Navy,
Air Force, Marines) between July 4, 1965 and March 28, 1973
with a 30-day minimum period of service in Vietnam, countries
near Vietnam, or in the United States. HealthViEWS consisted
of a mailed survey followed by a telephone interview, both
administered by a survey research company contracted by the
Department of Veterans Affairs (VA). The study was approved
by the VA Central Institutional Review Board.
Eligibility for the current substudy included return of the
mailed survey with complete data for the PTSD Checklist Civil-
ian Version (PCL-C; Weathers, Litz, Herman, Huska, & Keane,
1993), completion of the PTSD module of the CIDI as part of the
telephone interview, and agreement to complete an additional
telephone interview assessment of PTSD using the CAPS for
the purposes of this substudy. All eligible women (1,389) who
were approached to participate in the substudy at the conclusion
Table 1
Demographic Characteristics of Participants
Variable n %
Marital status
Married or partnered 81 50.6
Divorced or separated 41 25.6
Widowed 5 3.1
Never married 29 18.1
Race
White 138 86.3
African American 9 5.6
Asian/other 7 4.3
Education
High school diploma 10 6.3
Some college, vocational school,
Associates degree
22 13.8
Three-year degree/diploma 31 19.4
Four-year college degree 40 25.0
Some graduate school 10 6.3
Graduate/professional degree 44 27.5
Employed 127 79.4
Household income
< $15,000 10 6.3
$15,000–$29,999 15 9.4
$30,000–$49,999 36 22.5
$50,000–$74,999 29 18.1
$75,000–$99,999 24 15.0
$100,000–$149,999 29 18.1
$150,000 or more 8 5.0
PTSD Checklist score
30 68 42.5
<30 92 57.5
Note. N = 160. Missing data: Age, marital status, 4; race, 6; education, 3;
employment, 3; income, 9. PTSD = posttraumatic stress disorder.
of the telephone interview agreed to participate. One hundred
sixty-five women were recontacted and invited to participate in
a follow-up interview; the final sample consisted of 160 women
who completed the CAPS interview; five participants were ex-
cluded due to incomplete CAPS interviews. The average age of
women in the sample was 66.7 years (SD = 4.8). Demographic
characteristics of the sample are described in Table 1.
Procedure
The diagnostic concordance between the CIDI and the CAPS
was established as part of the Department of Veteran Af-
fairs Cooperative Study #579, an epidemiologic investigation
of the health status of women who served during the Viet-
nam era (HealthViEWS). The purpose was to quantify the
diagnostic certainty of the CIDI PTSD module diagnosis in
this population by assessing diagnostic concordance with the
CAPS. Valid assessment of diagnostic concordance requires
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independent, blinded administration of the test diagnosis and
criterion, so that results of each assessment do not influence the
other, artificially increasing diagnostic concordance, but within
a sufficiently short interval of time so that diagnostic concor-
dance is not decreased due to fluctuation in symptoms over time.
The current study evaluated 160 women for both past-year and
lifetime PTSD using independent, blinded administration of the
CIDI PTSD module and CAPS within a 3-week interval.
Representative samples are necessary in studies of diagnos-
tic accuracy, but when the prevalence of a condition is low,
sequential or simple random sampling requires very large, of-
ten infeasible, sample sizes to estimate agreement statistics with
acceptable levels of precision. Smaller samples may yield too
few positive diagnoses to estimate accuracy with precision (e.g.
Alegria et al., 2004). Under such conditions, balanced samples
can be achieved using stratified sampling (Clarke et al., 2013;
Knottnerus & Muris, 2003). We employed this sampling ap-
proach by prescreening participants for current PTSD symp-
toms using the PCL-C to try to oversample cases with current
PTSD. The PCL-C was completed as part of a HealthViEWS
survey prior to study recruitment. Stratified designs must cau-
tion against only sampling extreme cases of high or low symp-
toms and excluding of indeterminate or subthreshold cases.
Excluding cases where discrimination is most difficult can up-
wardly bias estimates of diagnostic accuracy, and is known as
spectrum bias. To further guard against spectrum bias, a sen-
sitive cut score ( 30; McDonald & Calhoun, 2010; Yeager,
Magruder, Knapp, Nicholas, & Frueh, 2007) was used to ensure
a wide range of PTSD symptoms was represented, including
threshold cases. Of the 160 women in the sample, 68 scored
above the PCL-C threshold; 92 scored below. Scores ranged
from 17 to 76, with a median PCL-C score of 28 (IQR = 19–
43), suggesting threshold cases were represented in the sample.
Women who were eligible for the current substudy were so
indicated in the CATI interview system in the HealthViEWS
telephone survey. At the conclusion of the telephone survey,
women were asked if they would be willing to be contacted to
complete a second telephone interview for which they would
be compensated an additional $75. Contact information for
women who agreed to participate was forwarded to study staff
at the Charleston VA Medical Center, and these women were
contacted sequentially in blocked recruitment periods for study
interviews within 3 weeks of completing the HealthViEWS
telephone interview. The CIDI PTSD module was completed
during the HealthViEWS telephone interview by trained survey
research interviewers blind to survey results, including PCL-C
scores. The CAPS assessment was completed independently
via telephone by the Charleston VAMC study staff. All CAPS
assessments were conducted subsequent to CIDI interviews,
but blind to CIDI results and PCL-C.
The CIDI module was administered by trained, experienced
lay interviewers who conducted the HealthViEWS telephone
interview. Interviewers had between 2 and 20 years experience
with a large survey research company and prior experience with
surveys that included sensitive topics. In addition to standard
training on telephone interviewing, study-specific training, and
VA research training, interviewers received substantial instruc-
tion on CIDI administration. Supervisors attended intensive
CIDI training through the WHO-CIDI 3.0 training program in
Ann Arbor, Michigan. The training consisted of a compact disc
of take-home lessons that were completed before a 3-day in-
person training. During the first 2 days, certified WHO-CIDI
trainers provided extensive training on conducting the inter-
view, quality control, and standardized interviewing. On the
third day, all attendees were required to participate in a certifi-
cation interview. Supervisors then provided training to survey
research interviewers using CIDI manuals and training materi-
als for self-study, group teleconference trainings, and comple-
tion of practice interviews to establish competence. Monitoring
by a supervisor was conducted on 10% of all CIDI interviews,
with subsequent training provided when necessary.
The CAPS assessment was administered by trained medi-
cal clinicians: two doctoral-level psychiatric nurses, a research
nurse, and a research physician. All interviewers had a mini-
mum of 5 years of experience in clinical mental health. Two in-
terviewers had extensive prior research experience with CAPS
administration. The study coordinator (a doctoral-level psychi-
atric nurse who also performed interviews) provided a 6-hour
interactive refresher training class for CAPS interviews to the
interviewers. Three of the first interviews for all four clinicians
were recorded. The recordings were scored independently by
one or two other interviewers to ensure scoring fidelity.
Measures
Diagnostic interviews for PTSD. The PTSD module of
the CIDI version 3.0, CAPI version 20, was used for the di-
agnosis of past-year and lifetime PTSD (Kessler et al., 2004).
The CIDI is a structured interview designed to assess psy-
chiatric disorders according to criteria based on the DSM-IV
(4th ed.; DSMIV; American Psychiatric Association, 1994)
and the ICD-10: International Statistical Classification of Dis-
eases and Related Health Problems (World Health Organiza-
tion, 1992). The PTSD module includes 26 questions to identify
potentially traumatic events, and a query for additional events
not listed. Participants who report any event are asked addi-
tional items to confirm PTSD event criteria of fear, horror, or
helplessness. Participants who meet DSM-IV trauma exposure
criteria are then asked about PTSD symptoms in reference to
the worst event (as selected by the participant) and a randomly
selected event. There are 17 items with a yes or no response
format, with additional questions about symptom onset and
recency. The CIDI was scored using the WHO computerized
scoring algorithm corresponding to DSM-IV PTSD criteria. The
CIDI PTSD module yields information regarding past-year and
lifetime PTSD diagnostic status.
The CAPS (Blake et al., 1995) was used as the diagnostic cri-
terion for past-year and lifetime PTSD. The CAPS is a widely
used reliable and valid structured clinical interview for PTSD
(Weathers et al., 2001). Respondents are first asked about the
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occurrence of 20 potentially traumatic events. Those who re-
port any events are then asked additional items to confirm PTSD
event criteria of fear, horror, or helplessness in reference to up
to three events. Those who meet trauma-exposure criteria are
then asked detailed questions about the intensity and frequency
of the 17 DSM-IV PTSD symptoms in reference to these three
events, with standardized probes and clarification. Frequency
and intensity of symptoms are each rated on a 0–4 scale. The
CAPS is scored according to DSM-IV criteria. The most com-
mon method for establishing that a symptom is present if the
item frequency score is >1 and the intensity score  2 (F1/I2
scoring rule; Weathers et al., 2001), which was used for the
current analyses to facilitate interpretation of results. Because
this is also one of the more lenient scoring rules, sensitivity
analyses were conducted comparing results obtained with this
scoring rule to those obtained with a more-conservative scoring
method, using the F1/I2 rule but also requiring a total score of
65 or greater (F1/I2/Sev65; Weathers et al., 2001).
The CAPS traditionally yields a current (past month) and
lifetime PTSD diagnosis. The time frame for the CAPS current
diagnosis was modified to a past-year diagnosis, to achieve
correspondence with the CIDI-PTSD, which yields a past-
year diagnosis. This modification was made in collabora-
tion with the primary author of the CAPS, to decrease er-
ror in diagnostic concordance due to differing time frames
for recent diagnosis between the CIDI and the CAPS. A re-
sponse prompt was added to CAPS instructions stating “in the
past year . . . ” to assess symptoms consistent with a past-year
diagnosis.
Self-report measures. The PCL-C (Weathers et al., 1993)
was used as a self-report measure of PTSD symptoms to stratify
recruitment and was included as part of the mail survey. The
PCL-C is a 17-item measure of DSM-IV PTSD symptoms. Re-
spondents are introduced to “a list of problems and complaints
that veterans sometimes have in response to stressful experi-
ences” and are then asked to rate how much each symptom has
bothered them during the past month using a 5-point scale (1 =
not at all to 5 = extremely). The total PCL-C score is calculated
by summing scores for the 17 items and can range from 17
to 85. The Cronbach’s α for the current sample was .93. The
PCL has good evidence for its use as a screening tool, espe-
cially when used with a sensitive cut score followed by further
diagnostic assessment (McDonald & Calhoun, 2010) as in the
current study. The PCL-C was selected over the PCL-M for the
current study to capture all PTSD symptoms, not only those as-
sociated with a military-related traumatic event. Demographic
characteristics were also self-reported on the mail survey.
Data Analysis
Analyses were completed using SAS Version 9.2. Concordance
between the CIDI and CAPS diagnoses was examined using the
CAPS diagnosis as the criterion for both past-year and lifetime
PTSD. There were no missing data for these measures. The area
under the ROC curve (Hanley & McNeil, 1982) was used as an
indicator of CIDI PTSD module accuracy. The area under the
ROC curve values range from 0 to 1 where an area under the
ROC curve above .5 indicates accuracy greater than chance. We
also calculated sensitivity, specificity, and diagnostic likelihood
ratios with 95% CIs. Kappa was calculated as an indicator of
the chance-adjusted agreement between the two tests. The κ
statistic can also be conceptualized as the quality of a diagnostic
test’s overall discriminative ability (Kraemer, 1992). Similarly,
estimates of the quality of sensitivity κ (1.0) and the quality
of specificity κ (0.0) were calculated as standardized indicators
of sensitivity and specificity. The target range for κ values was
.4 to .6. Though traditionally considered a moderate level of
agreement (Landis & Koch, 1977), when contextualized within
subsequent research into the quality of medical diagnoses, this
range has been proposed as a realistic target for agreement
across dichotomous diagnoses, where a κ of .6 to .8 would
be considered an exceptional quality of agreement (Kraemer,
Kupfer, Clarke, Narrow, & Regier, 2012).
Sensitivity analyses were calculated to assess the impact of
the CAPS scoring rule, comparing results of the lenient (F1/I2)
and more conservative (F1/I2/Sev65) scoring rules. The area
under the ROC curve for results from each scoring rule was
compared and McNemar tests were used to compare results
from each scoring rule on the proportions of true positive CIDI
diagnoses, and the proportions of false positive CIDI PTSD
module diagnoses for lifetime PTSD (Pepe, 2003). Results re-
vealed no statistically significant differences between estimates
obtained from each scoring rule, so all analyses are reported us-
ing the more commonly used F1/I2 scoring rule for the CAPS.
Results
The diagnostic concordance of the CIDI with the CAPS is de-
scribed in Table 2. Criteria for lifetime PTSD according to the
CAPS were met by 45.0% of the sample, and 33.7% were di-
agnosed with PTSD on the CIDI. The CIDI correctly classified
78.8% of cases and κ was .56. Estimates of diagnostic accuracy
for the CIDI, using the CAPS as diagnostic criterion yielded a
positive LR was 7.03 and negative LR was 0.40.
Criteria for past-year PTSD according to the CAPS were
met by 21.9% of the sample, and 27.5% of the sample were
diagnosed with PTSD on the CIDI. The CIDI correctly classi-
fied 82% of cases; κ was .52. Estimates of diagnostic accuracy
for the CIDI, using the CAPS as diagnostic criterion yielded a
positive LR was 4.70 and negative LR was 0.34.
We examined misclassified cases by analyzing false nega-
tives and false positives separately. False negative cases were
the 26 cases diagnosed with lifetime PTSD by the CAPS, but
missed by the CIDI. Among these cases, 11 (42%) demonstrated
subthreshold levels of PTSD symptoms on the CIDI, meeting
criteria for partial PTSD (Stein, Walker, Hazen, & Forde, 1997),
defined as fewer than the required number of symptoms for ei-
ther Criteria C or D, or failed to meet only the E or F criteria.
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Table 2
Estimates of Diagnostic Accuracy for the CIDI Compared to the CAPS as Diagnostic Criterion for PTSD
CAPS CIDI
Variable n % n % AUC 95% CI Sens 95% CI Spec 95% CI
Lifetime PTSD 72 45% 54 33.7% 0.77 [0.71, 0.84] 0.64 [0.52, 0.75] 0.91 [0.83, 0.96]
Past-year PTSD 35 21.9% 44 27.5% 0.78 [0.70, 0.86] 0.71 [0.54, 0.85] 0.85 [0.77, 0.91]
LR+ 95% CI LR− 95% CI κ 95% CI κ (1) κ (0)
Lifetime PTSD 7.03 [3.55, 13.92] 0.40 [0.29, 0.54] 0.56 [0.43, 0.69] 0.45 0.73
Past-year PTSD 4.70 [2.96, 7.47] 0.34 [0.20, 0.57] 0.52 [0.36, 0.67] 0.61 0.45
Note. PTSD = posttraumatic stress disorder; CAPS = Clinician Administered PTSD Scale; CIDI = Composite International Diagnostic Interview; AUC = area under
the receiver operating characteristic curve; Sens = sensitivity; Spec = specificity; LR+ = positive likelihood ratio; LR− = negative likelihood ratio; κ(1) = quality of
the sensitivity; κ(0) = quality of the specificity.
Five cases did not meet trauma-exposure criteria on the CIDI,
and were not assessed for PTSD symptoms due to skip patterns.
False positives were the eight cases that were not diagnosed
with lifetime PTSD by the CAPS, but met criteria for lifetime
PTSD on the CIDI. Among these cases, five demonstrated sub-
threshold levels of PTSD on the CAPS, meeting criteria for all
but one symptom cluster.
Discussion
This study supports the use of the CIDI PTSD module for iden-
tification of PTSD among women veterans of the Vietnam era.
Using CAPS as the diagnostic criterion, the CIDI correctly clas-
sified approximately 80% of cases (79% lifetime PTSD; 82%
past-year PTSD), with κ coefficients for diagnostic concordance
well within the target range. The clinical significance of the area
under the ROC curve, as a measure of diagnostic accuracy (.77
for lifetime, .78 for past-year) indicates a very large effect size
(Kraemer et al., 2003), lending further support to the CIDI as a
diagnostic tool for PTSD. The strengths of this study, including
independent, blinded assessments, both assessments occurring
within 3 weeks of each other, a sensitive and detailed reference
standard, and a sample size sufficient to examine both life-
time and past-year PTSD, lend further confidence to our data,
suggesting that the CIDI 3.0 PTSD module is an acceptable
diagnostic tool for PTSD among female Vietnam-era veterans,
and a promising instrument for use with other populations.
A clinician-administered diagnostic interview with the sen-
sitivity and detail that the CAPS provides is not feasible for
large-scale epidemiological studies, making the CIDI an at-
tractive alternative. Even a comprehensive and structured lay-
administered interview, however, such as the CIDI cannot be
expected to achieve a level of precision similar to a clinical inter-
view. Some measurement error in the epidemiological diagnosis
of PTSD using the CIDI is therefore unavoidable, though in this
case the limitation is balanced by the fact that use of the CIDI
permits a large sample size and external validity rarely afforded
by clinical studies. The CIDI appears to be a somewhat con-
servative indicator of PTSD, demonstrating better specificity
(ability to rule out negative cases) as compared to sensitivity
(the ability to detect positive cases), for lifetime diagnoses. This
direction of misclassification bias is appropriate: An overly sen-
sitive instrument would bias away from the null hypothesis, and
inflate both prevalence estimates and the ability to detect sta-
tistically significant associations. A more-specific instrument
biases results towards the null hypothesis, and increases confi-
dence in effects that do achieve statistical significance.
Our study found stronger support for the CIDI’s diagnosis
of PTSD as compared to evaluations of diagnostic accuracy in
the WHO World Mental Health Surveys (Alegria et al., 2009;
Haro et al., 2006; Kraemer et al., 2003), especially with re-
spect to the instrument’s sensitivity. Our accuracy results are
more comparable to those using version 2.1 of the CIDI PTSD
module (Breslau et al., 1998), possibly because both studies
were powered specifically to examine PTSD diagnoses. Bres-
lau and colleagues did find, in contrast to our results, the CIDI
to be more sensitive than specific in the diagnosis of lifetime
PTSD. In both the Breslau et al. (1998) study and the current
study, however, the majority of false positive cases on the CIDI
were identified as subthreshold cases of PTSD by the CAPS.
These results lend further confidence to PTSD diagnoses estab-
lished by the CIDI. Correspondingly, the largest group of false
negative diagnoses by the CIDI also met criteria for subthresh-
old PTSD. A substantial literature has addressed the common
frequency and clinical significance of partial or subthreshold
DSM-IV PTSD (Grubaugh et al., 2005; Marshall et al., 2001;
Pietrzak, Goldstein, Southwick, & Grant, 2011), and for such
cases there will always be some degree of diagnostic uncertainty
in the administration of any single measure.
This study should be interpreted in light of several consid-
erations. Most important, though promising, our results do not
necessarily generalize to other populations, and additional re-
search is needed to determine the specific psychometric proper-
ties of the CIDI 3.0 PTSD module with males, nonveterans, and
other age groups. The short interval of time between the CIDI
interview and the CAPS assessment is a strength of the study,
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but because we did not vary the order of administration of the
CIDI and the CAPS, participants may have been primed by the
CIDI interview for traumatic events and PTSD symptoms, re-
sulting in enhanced event and symptom reporting for the CAPS.
Finally, as noted by Haro et al. (2006), inferences about the va-
lidity of any diagnostic interview must be considered in the
context of measurement error in the diagnostic gold standard.
The CAPS test-retest reliability of .89 (Weathers et al., 2001)
is very good, but as with all measures, imperfect. Our results
should therefore be interpreted as a lower-bound estimate of
CIDI accuracy.
In summary, our results support the diagnostic utility of the
CIDI PTSD module among female Vietnam-era veterans and
provide incremental support, along with Breslau and colleagues
(1998), for the diagnostic utility of the CIDI. Although future
research should continue to examine the CIDI in trauma popu-
lations of interest, we suggest that the CIDI PTSD module ap-
pears to be an acceptable epidemiological tool to detect PTSD
among women veterans.
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